Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 8/20 | 0.47 |
| ▸ | F10 | P00742 | 3/20 | 0.36 |
| ▸ | MAOB | P27338 | 7/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | CALML3 | P27482 | 1/20 | 0.35 |
| ▸ | SDHA | P31040 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3048401 | 0.89 | F10 (0.36) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL5862835 | 0.85 | MAOA (0.48) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL3039246 | 0.82 | MAOA (0.56) | MAOAMAOBLMNAPTGS1CALML3 | |
| SCHEMBL5998601 | 0.79 | MAOA (0.51) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL3029206 | 0.78 | MAOA (0.47) | MAOAF10MAOB | |
| SCHEMBL6686796 | 0.78 | MAOA (0.47) | MAOAF10MAOB | |
| SCHEMBL3032928 | 0.77 | MAOA (0.47) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL3039330 | 0.77 | F10 (0.56) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL5862218 | 0.76 | MAOA (0.39) | MAOAF10MAOBLMNAPTGS1 | |
| SCHEMBL3036010 | 0.76 | MAOA (0.46) | MAOAF10MAOBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111638632-B | Photoresist reworking liquid composition for CF procedure | 福建省佑达环保材料有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-111704963-A | Water-based cleaning agent for cleaning liquid crystal | 福建省佑达环保材料有限公司 | 2020-09-25 | — | — | CN | claimed |
| CN-111638632-A | Photoresist reworking liquid composition for CF procedure | 福建省佑达环保材料有限公司 | 2020-09-08 | — | — | CN | claimed |
| CN-103772064-A | Seed dressing containing pyrrolidine methanol derivative | ANHUI LAIMUJIA FERTILIZER INDUSTRY CO LTD | 2014-05-07 | — | — | CN | claimed |
| US-20040147760-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-29 | — | — | US | claimed |
| CN-111638632-B | Photoresist reworking liquid composition for CF procedure | 福建省佑达环保材料有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-111704963-B | Water-based cleaning agent for cleaning liquid crystal | 福建省佑达环保材料有限公司 | 2021-06-01 | — | — | CN | disclosed |
| CN-111704963-A | Water-based cleaning agent for cleaning liquid crystal | 福建省佑达环保材料有限公司 | 2020-09-25 | — | — | CN | disclosed |
| CN-111638632-A | Photoresist reworking liquid composition for CF procedure | 福建省佑达环保材料有限公司 | 2020-09-08 | — | — | CN | disclosed |
| CN-110545850-A | Releasable conjugates | QUIAPEG PHARMACEUTICALS AB | 2019-12-06 | — | — | CN | disclosed |
| CN-103547558-B | Preparation is containing the method for 5-membered ring compounds | ONO PHARMACEUTICAL CO.,LTD. (JP) | 2016-03-16 | — | — | CN | disclosed |
| EP-2703381-B1 | METHOD FOR PRODUCING FIVE-MEMBERED RING-CONTAINING COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2015-10-21 | — | — | EP | disclosed |
| EP-1107969-A2 | COLLECTIONS OF COMPOUNDS | Spirogen Limited (GB) | 2001-06-20 | — | — | EP | disclosed |
| EP-1107970-A2 | COLLECTIONS OF COMPOUNDS | Spirogen Limited (GB) | 2001-06-20 | — | — | EP | disclosed |
| CN-1257068-A | Process for preparation of condensed sulfamide | SHIONOGI & CO (JP) | 2000-06-21 | — | — | CN | disclosed |
| CN-1052474-C | Process for preparing sulfamide | SHIONOGI SEIYAKU KK (JP) | 2000-05-17 | — | — | CN | disclosed |
| WO-2000012506-A2 | COLLECTIONS OF COMPOUNDS | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012508-A2 | PYRROLBENZODIAZEPINES | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012509-A2 | COLLECTIONS OF COMPOUNDS | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| CN-1078718-A | process for preparing sulfamide | SHIONOGI & CO (JP) | 1993-11-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147760-A1 | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives | OXA1L, AADAC, MT-ND5 | MAOA 957/4885F10 4479/4885MAOB 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.